MoP Research Questions

Own Heritage Object

Phase 1 (July 2014 – June 2015):
• How do existing social prescribing schemes work in UK cultural and arts organisations (and selected countries including Australia, New Zealand, Canada, US and EU)?
• How were such schemes set up, who are the participants, what partners are involved and what were the critical success factors in implementation?
• What is the value and impact of such schemes to participants (e.g. patients) and key stakeholders (e.g. hosting organisations, local government, referrers)?

Phase 2 (July 2015 – June 2017):
• In the development of a new social prescription scheme (Museums on Prescription; MoP), targeting older adults, what will be the critical success factors in implementation, and what are the cost-benefits?
• What is the value and impact of a MoP scheme for older adult participants in relation to social isolation, loneliness, psychological and subjective wellbeing?
• What is the value and impact of a MoP scheme for stakeholders (museums, health/social care providers, third sector organisations) in two distinct settings: an urban setting (Central London) compared to a regional setting (Kent)?
• What is the value and impact of a MoP scheme for a small museum (e.g. Islington Museum, The Beaney Museum) compared to a larger national museum (e.g. The British Museum)?
• How can lessons learned from the development of novel MoP schemes be used to inform the practice of other museums through the creation of a standardised MoP model?
• How transferable will a MoP model be to other museums?
• What can different data collection methodologies and techniques, from across the humanities, social sciences and health, tell us about understanding the value and impact of cultural activities on health and wellbeing.